• Home
  • Search
  • Toward an effective AIDS vaccine development
  • Cite Icon1
  • https://doi.org/10.1002/eji.201370125Copy DOI Icon

Toward an effective AIDS vaccine development

Show More
  • Abstract
  • Literature Map
  • References
  • Citations
  • Similar Papers
Abstract

Toward an effective AIDS vaccine development

Similar Papers
  • Discussion
  • Citations1

Underquantification of plasma HIV-1 RNA levels in a cohort of newly-diagnosed individuals

  • Mar 30, 2010
  • International Journal of Infectious Diseases
  • Philippe Colson +2
  • Research Article
  • Citations20

Human Immunodeficiency Virus Type 1 Escapes from Interleukin-2-Producing CD4 + T-Cell Responses without High-Frequency Fixation of Mutations

  • Jun 24, 2009
  • Journal of Virology
  • R Brad Jones +10
  • Research Article
  • Citations2

HCV adaptations to altered CD8+ T-cell immunity during pregnancy.

  • Apr 01, 2014
  • Future virology
  • Aryn A Price +2
  • Research Article

The expression of CD39 on NK cells relates to poor HIV-1 suppression in treatment-naïve HIV-1-infected individuals: Association with elevated IL-10 secretion and TIGIT co-expression.

  • Mar 01, 2026
  • Virologica Sinica
  • Xin Zhang +12
  • Research Article
  • Citations119

AIDS clinical trials group 5197: a placebo-controlled trial of immunization of HIV-1-infected persons with a replication-deficient adenovirus type 5 vaccine expressing the HIV-1 core protein.

  • Sep 01, 2010
  • The Journal of Infectious Diseases
  • Robert T Schooley +12
  • PDF
  • Research Article
  • Citations14

Performance evaluation of a laboratory developed PCR test for quantitation of HIV-2 viral RNA.

  • Feb 28, 2020
  • PloS one
  • Linda L Jagodzinski +4
  • Research Article
  • Citations615

Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine

  • Nov 28, 2013
  • New England Journal of Medicine
  • Scott M Hammer +29
  • Front Matter
  • Citations1

Rethinking hepatitis C viral kinetics: Insights into host-virus interactions in ‘difficult-to-treat’ groups and implications for novel treatment approaches

  • Aug 24, 2005
  • Journal of Hepatology
  • Elaine Yeung +1
  • Research Article
  • Citations62

At Least Five HIV-1 Sequence Subtypes (A, B, C, D, A/E) Occur in England

  • Mar 01, 1995
  • AIDS Research and Human Retroviruses
  • Catherine Arnold +3
  • Research Article
  • Citations122

Direct Evidence of Lower Viral Replication Rates In Vivo in Human Immunodeficiency Virus Type 2 (HIV-2) Infection than in HIV-1 Infection

  • Feb 28, 2007
  • Journal of Virology
  • Adam Macneil +5
  • Research Article
  • Citations23

Adenovirus 5 serotype vector-specific immunity and HIV-1 infection: a tale of T cells and antibodies

  • Mar 27, 2010
  • AIDS
  • M Patricia D'Souza +1
  • Research Article
  • Citations89

Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection

  • Oct 12, 2011
  • Clinical Infectious Diseases
  • P Rieder +12
  • Research Article

Conserved broad HIV-1 Gag-specific responses associated with low viral load and high CD4+ T cell nadir and preserved HAART regimen.

  • Jan 01, 2021
  • Acta virologica
  • Luciano Rodrigo Lopes +2
  • PDF
  • Research Article
  • Citations20

CD4:CD8 lymphocyte ratio as a quantitative measure of immunologic health in HIV-1 infection: findings from an African cohort with prospective data

  • Jul 01, 2015
  • Frontiers in Microbiology
  • Jianming Tang +11
  • Research Article
  • Citations34

First-in-Human Evaluation of the Safety and Immunogenicity of an Intranasally Administered Replication-Competent Sendai Virus–Vectored HIV Type 1 Gag Vaccine: Induction of Potent T-Cell or Antibody Responses in Prime-Boost Regimens

  • Oct 17, 2016
  • The Journal of Infectious Diseases
  • Julien Nyombayire +26
Cactus Communications logo

Copyright 2026 Cactus Communications. All rights reserved.